DEVELOPMENT AND EVALUATION OF MORINGA SUSPENSION BY USING XANTHANGUM AND VEEGUM AND COMPARING WITH MARKETED PRODUCT
Abstract
Moringa oleifera is a highly valued medicinal plant known for its extensive nutritional and pharmacological benefits. It contains various bioactive constituents such as flavonoids, phenolic compounds, alkaloids, vitamins, and minerals that exhibit antioxidant, anti-inflammatory, antimicrobial, and antidiabetic properties. Despite its therapeutic potential, the direct use of Moringa powder may present challenges such as poor palatability, variable dosing, and reduced bioavailability of certain phytoconstituents. To overcome these limitations, the present study was undertaken to develop and evaluate an oral Moringa suspension with improved stability, uniformity, and patient compliance. The suspension was formulated using suitable suspending agents such as xanthan gum and veegum to ensure proper dispersion of the Moringa extract. Additional excipients including preservatives, sweeteners, and flavoring agents were incorporated to enhance stability and acceptability. The formulated suspension was evaluated for various physicochemical parameters including organoleptic properties, pH, viscosity, sedimentation volume, redispersibility, particle size distribution, and in vitro stability studies. The results indicated that the prepared suspension exhibited satisfactory physical stability, good sedimentation characteristics with easy redispersibility, acceptable viscosity, and uniform drug content. Stability studies confirmed that the formulation remained stable under recommended storage conditions without significant changes in physical appearance or pH. The developed Moringa suspension demonstrated desirable pharmaceutical characteristics and improved patient compliance, making it a promising herbal oral dosage form for therapeutic use. This formulation approach may enhance the effectiveness and accessibility of Moringa-based herbal preparations in clinical practice.
Downloads
References
2. Gandji K, Chadare FJ, Idohou R, Salako VK, Assogbadjo AE, Glèlè KRL. Status and utilisation of Moringa oleifera Lam.: a review. Afr Crop Sci J. 2018;26:137–156. doi:10.4314/acsj.v26i1.10.
3. Chaudhary K, Chourasia S. Nutraceutical properties of Moringa oleifera: a review. EJPMR. 2017;4:646–655.
4. Gopinath LR, Jeevitha S, Gokiladevi T, Archaya S. Isolation and identification of therapeutic compounds from Moringa oleifera and its antimicrobial activity. IOSR J Pharm Biol Sci. 2017;12:1–10.
5. Kasolo JN, Bimenya GS, Ojok L, Ochieng J, Ogwal-Okeng JW. Phytochemicals and uses of Moringa oleifera leaves in Ugandan rural communities. J Med Plant Res. 2010;4:753–757.
6. Anwar F, Ashraf M, Bhanger MI. Interprovenance variation in the composition of Moringa oleifera oil seeds from Pakistan. J Am Oil Chem Soc. 2005;82:45–51. doi:10.1007/s11746-005-1041-1.
7. Ansari MM, Kumar SD. Fortification of food and beverages with phytonutrients. Public Health Nutr. 2012;2:241–253.
8. Choudhary MK, Bodakhe SH, Gupta SK. Assessment of the antiulcer potential of Moringa oleifera root-bark extract in rats. J Acupunct Meridian Stud. 2013;6:214–220. doi:10.1016/j.jams.2013.07.003.
9. Posmontier B. The medicinal qualities of Moringa oleifera. Holist Nurs Pract. 2011;25:80–87. doi:10.1097/HNP.0b013e31820dbb27.
10. Aekthammarat D, Pannangpetch P, Tangsucharit P. Moringa oleifera leaf extract lowers high blood pressure by alleviating vascular dysfunction and decreasing oxidative stress in L-NAME hypertensive rats. Phytomedicine. 2019;54:9–16. doi:10.1016/j.phymed.2018.10.023.
11. Tayo GM, Pone GW, Komtangi MC, Yondo G, Ngangout AM, Mbida M. Anthelmintic activity of Moringa oleifera leaf extracts evaluated in vitro on four developmental stages of Haemonchus contortus from goats. AJPS. 2014;5:1702–1710. doi:10.4236/ajps.2014.511185.
12. Hannan MA, Kang JY, Mohibbullah M, Hong YK, Lee H, Choi JS, et al. Moringa oleifera with promising neuronal survival and neurite outgrowth promoting potentials. J Ethnopharmacol. 2014;152:142–150. doi:10.1016/j.jep.2013.12.036.
13. Paikra BK, Dhongade HKJ, Gidwani B. Phytochemistry and pharmacology of Moringa oleifera Lam. J Pharmacopuncture. 2017;20:194–200. doi:10.3831/KPI.2017.20.022.
14. Mallenakuppe R, Homabalegowda H, Gouri MD, Basavaraju PS, Chandrashekharaiah UB. History, taxonomy and propagation of Moringa oleifera: a review. Int J Life Sci. 2019;5:2322–2327.
15. Guevara AP, Vargas C, Sakurai H, Fujiwara Y, Hashimoto K, Maoka T, et al. An antitumor promoter from Moringa oleifera Lam. Mutat Res. 1999;440:181–188. doi:10.1016/S1383-5718(99)00025-X.
16. Vimala G, Gricilda Shoba F. A review on antiulcer activity of few Indian medicinal plants. Int J Microbiol. 2014;2014:519590. doi:10.1155/2014/519590.
17. Popoola JO, Obembe OO. Local knowledge, use pattern and geographical distribution of Moringa oleifera Lam. (Moringaceae) in Nigeria. J Ethnopharmacol. 2013;150:682–691. doi:10.1016/j.jep.2013.09.043.
18. Swati A, Virk AK, Kumari C, Ali A, Garg P, Thakur P, et al. Moringa oleifera—A never die tree: an overview. Asian J Pharm Clin Res. 2018;11:57–65. doi:10.22159/ajpcr.2018.v11i12.28049.
19. Gopalakrishnan L, Doriya K, Kumar DS. Moringa oleifera: a review on nutritive importance and its medicinal application. Food Sci Hum Wellness. 2016;5:49–56. doi:10.1016/j.fshw.2016.04.001.
20. Stohs SJ, Hartman MJ. Review of the safety and efficacy of Moringa oleifera. Phytother Res. 2015;29:796–804. doi:10.1002/ptr.5325.

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

.